Compare NBIX & PFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | PFGC |
|---|---|---|
| Founded | 1992 | 1885 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 13.0B |
| IPO Year | 1996 | 2014 |
| Metric | NBIX | PFGC |
|---|---|---|
| Price | $149.94 | $93.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 9 |
| Target Price | ★ $180.91 | $116.44 |
| AVG Volume (30 Days) | 1.1M | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 1.91 | 1.26 |
| Revenue | $161,626,000.00 | ★ $17,619,900,000.00 |
| Revenue This Year | $24.73 | $15.14 |
| Revenue Next Year | $13.14 | $6.61 |
| P/E Ratio | ★ $77.03 | $93.79 |
| Revenue Growth | ★ 977.51 | 5.12 |
| 52 Week Low | $115.66 | $80.82 |
| 52 Week High | $160.18 | $109.05 |
| Indicator | NBIX | PFGC |
|---|---|---|
| Relative Strength Index (RSI) | 76.44 | 60.04 |
| Support Level | $133.96 | $91.34 |
| Resistance Level | $158.92 | $96.64 |
| Average True Range (ATR) | 3.63 | 2.79 |
| MACD | 2.00 | 0.25 |
| Stochastic Oscillator | 98.20 | 67.92 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Performance Food Group Co , markets and distributes national and company-branded food and food-related products. The company also specializes in distributing candy, snacks, beverages, cigarettes, other tobacco products, health and beauty care products and other items to vending distributors, box retailers, theaters, convenience stores, drug stores, grocery stores, travel providers, and hospitality providers. The company has three reportable segments: Foodservice, Vistar, and Convenience.